At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Celect Platinum Vena Cava Filter (device)
- How long the study runs
- Study runs about 66 months (dates as stated)
- About the drug or intervention
- Celect Platinum Vena Cava Filter — device: Inferior vena cava filter
- Patient visit burden
- Not specified by the sponsor
In plain English
This study collects information about patients who have a Celect Platinum Vena Cava Filter put in place. A vena cava filter is a small device placed in a large vein to help stop blood clots, such as those linked to deep vein thrombosis (a blood clot in a deep vein) or pulmonary embolism (a blood clot in the lungs), from travelling to the lungs. The study is run by Cook Research Incorporated.
Who can take part
- Patients who have a procedure where a Celect Platinum Vena Cava Filter is placed
- Patients who have not taken part in the Cook MDR-2126 study before
Who may not be able to
- Patients (or their legally authorised representative) who object to their data being collected and processed, or who are not willing to sign the informed consent form
What taking part involves
- • Not stated — ask your trial team
- • Not stated — ask your trial team
Time commitment: Not stated — ask the trial team, as the registry entry does not say how long the study lasts, how many visits are needed, or what taking part involves.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 82
- Started
- 2025-06-02
- Last checked
- 2026-04
Plain English Summary
What is this study?
- • Testing a new treatment for deep vein thrombosis
- • Clinical study - 82 participants
- • This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and continued acceptability of the benefit:risk ratio
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with deep vein thrombosis
Where?
- • Leeds - Leeds Teaching Hospital NHS Trust
- • Hull - Hull University Teaching Hospitals NHS Trust
- • Liverpool - Royal Liverpool Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and continued acceptability of the benefit:risk ratio. Additionally, the study intends to evaluate longer-term (i.e., up to 5 years) outcome data while the filter is indwelling.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓A patient dataset is deemed suitable for inclusion if the patient has a procedure where a Celect Platinum Vena Cava...
- ✓Subject has not previously participated in the Cook MDR-2126 study.
See the full criteria
Where Is This Study? (3 UK sites)
Leeds Teaching Hospital NHS Trust
Leeds LS1 3EX, United Kingdom
Hull University Teaching Hospitals NHS Trust
Hull HU3 2JZ, United Kingdom
James Illingworth
hyp-tr.development.research@nhs.net01482 461883 or 461903Royal Liverpool Hospital
Liverpool L7 8XP, United Kingdom
How to Get in Touch
Sabina Andersen
Sponsor contactCONTACT